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A B S T R A C T
The validity of the chalcone scaffold for the design of inhibitors of monoamine oxidase had
previously been reported. A series of thiophene based chalcones were synthesized by the
reaction between 2-acetyl thiophene and substituted aromatic aldehyde according to the
Claisen-Schmidt condensation. The structures of the synthesized compounds were ascer-
tained by spectral analysis. Drug-likeness of the titled derivatives was done by blood–
brain barrier, Lipinski’s rule of 5 and in silico toxicity prediction. Using molecular docking
study, we proposed that the synthesized thiophene scaffolds can successfully dock into the
inhibitor binding pockets of monoamine oxidase B than A. In this series, 3-[4- (dimethyl amino)
phenyl]-1-(thiophen-2-yl) prop-2-en-1-one (Td) showed a docking score of −8.46 kcal/mol and
calculated inhibition constant of about 0.64 μM towards the active site of MAO-B.
© 2016 Beni-Suef University. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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1. Introduction
Monoamine oxidase (MAO) is a flavoenzyme responsible for
the regulation and metabolism of major monoamine neu-
rotransmitters such as 5-hydroxytryptamine, norepinephrine
and dopamine in the central nervous system (Shih et al., 1999).
The MAO enzyme exists in two forms namely MAO-A and MAO-B
on the basis of their molecular cloning, substrate and inhibitor
selectivity and tissue distribution (Bach et al., 1998; Johnston,
1968; Kalgutkar et al., 1995). Selective human MAO-A inhibi-
tors are used as antidepressants and anti-anxiety agents, while
selective human MAO-B inhibitors are used alone or in com-
bination in the therapy of Alzheimer’s disease and Parkinson’s
disease. (Carreiras and Marco, 2004; Fernandez and Chen, 2007;
Pacher and Kecskemeti, 2004; Yamada and Yasuhara, 2004).
Chalcones (1, 3-Diphenyl-2-propen-1-one) are constituted
by a three carbon α, β-unsaturated carbonyl system. The
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naturally occurring secondary metabolites such as flavo-
noids and isoflavonoids are biosynthesized from this precursor
unit. Chemically, they consist of open-chain flavonoids in which
the two aromatic rings are joined by a linker of three-carbon
α, β-unsaturated carbonyl system (Nowakowska, 2007). Chimenti
et al. (2005) synthesized a large series of substituted chalcones
and tested in vitro for their ability to inhibit human MAO-
A&B (Chimenti et al., 2009). At the same time, a great deal of
literature data has been established on the therapeutic journey
of heteroaryl chalcones such as antibacterial, antifungal, anti-
inflammatory, anti-HIV, anticancer, anti-angiogenic and
antimalarial (Bag et al., 2008; Lee et al., 2012; Mathew et al.,
2014a; Ramesh and Rao, 2010; Rizvi et al., 2012; Sashidhara et al.,
2012; Solomon and Lee, 2012; Zheng et al., 2011).
In 2013, Robinson et al. demonstrated that furan based
chalcones exhibited moderate to good inhibitory activities
towards MAO-B, but showed weak or no inhibition of the MAO-A
enzyme (Robinson et al., 2013). Interestingly, contrary to data
previously reported for chalcones, these furan substituted de-
rivatives acted as reversible inhibitors, while kinetic analysis
revealed a competitive mode of binding. The MAO inhibitory
action of furan based chalcone prompted us to design a series
of thiophene based chalcone and establish its molecular rec-
ognition in the inhibitor binding cavity of MAO-A and B. Most
of the current MAO inhibitors lead to side effects by a lack of
affinity and selectivity towards one of the isoforms (Reniers
et al., 2011). So it remains fundamental to design new more
potent, reversible and selective inhibitors of MAO isoforms.
Based upon the aforementioned literature data about the het-
erocyclic chalcones and the research interest of our monoamine
oxidase inhibitors (Mathew et al., 2013, 2014b), here, we report
the synthesis of thiophene based chalcones, preclinical evalu-
ation and molecular docking studies in the MAO-A and B. The
design of thiophene incorporated chalcones was shown in Fig. 1.
We aimed to present molecular insights into the binding modes
of these synthesized thiophene compounds in the active site
of MAO isoforms through the use of molecular modelling tools.
2. Materials and methods
2.1. Chemistry
Acetyl thiophene was procured from Sigma–Aldrich USA. All
other chemicals and reagents purchased from SD-fine and Nice
chemicals. Melting points of all the synthesized derivatives were
determined by open-capillary tube method and values were
uncorrected. IR spectra were recorded on Shimadzu FT/IR spec-
trometer on KBr pellets.1H NMR and 13C NMR spectra were
recorded on a Bruker 400 mhz NMR spectrometer using CDCl3
as the solvent. Mass spectra were recorded on a JEOL GCMate
mass spectrometer.
2.2. Softwares required
The receptor model was built by using AutoDock tools 1.4.6 and
MGL tools 1.5.4 packages (The Scripps Research Institute, Mo-
lecular Graphics Laboratory, 10550 North Torrey Pines Road, CA,
92037). ChemDraw Ultra 8.0. and Chem3D Ultra 8.0. (Cam-
bridge Soft.Com, 100 Cambridge park drive, Cambridge, MA
02140, USA) was used to draw and energy minimization for the
3D structures. In silico ADME properties were retrieved from
www.molinspiration.com and www.cbligand.org/BBB/. Toxic-
ity prediction was done by Osiris calculator.
2.3. Synthesis
A mixture of 2-acetyl thiophene (0.01 mol), aromatic alde-
hyde (0.01 mol) and 40% aqueous potassium hydroxide (15 ml)
in ethanol (30 ml) was stirred at room temperature for about
2 hr. The resulting product was kept overnight in refrigerator.
The mixture was poured into crushed ice and acidified with
5% HCl. The solid separated was filtered, washed with water
and recrystallized from ethanol.
2.3.1. 3-phenyl-1-(thiophen-2-yl) prop-2-en-1-one (Ta)
Cream white, yield 86%, m.p. 64 °C. FT-IR (KBr) vmax/cm−1:
1682(C = O), 1510(CH = CH), 730(C-S-C). 1H NMR (CDCl3, 400 MHz,
δ ppm): 6.63(1H, d, J = 15.6 Hz, -CO-CH=), 7.16–7.41(8H, m, J = 6.6–
8.8 Hz, Ar-H& Th-H) 7.47(1H, d, J = 16 Hz, =CH-Ar). MS: m/z (M+1)
214. Anal. calcd. for C13H10OS: C, 72.87; H, 4.70; S, 14.96. Found:
C, 72.81; H, 4.82; S, 14.88.
2.3.2. 3-(4-chlorophenyl)-1-(thiophen-2-yl)
prop-2-en-1-one (Tb)
White, yield 90%, m.p.128 °C. FT-IR (KBr) vmax/cm−1: 1647(C = O),
1517(CH = CH), 825(Ar-Cl), 719(C-S-C). 1H NMR (CDCl3, 400 MHz,
δ ppm): 6.82(1H, d, J = 15.2 Hz, -CO-CH=), 7.26–7.40(7H, m, J = 6.6–
8.8 Hz, Ar-H& Th-H), 7.48(1H, d, J = 15.6 Hz, =CH-Ar). MS: m/z
(M+2) 248. Anal. calcd. for C13H9ClOS: C, 62.78; H, 3.65; S, 12.89.
Found: C, 62.67; H, 3.63; S, 12.73.
2.3.3. 3-(4-methoxyphenyl)-1-(thiophen-2-yl)
prop-2-en-1-one (Tc)
Yellow, yield 90%, m.p.68 °C. FT-IR (KBr) vmax/cm−1: 1647(C = O),
1516(CH = CH), 731(C-S-C). 1H NMR (CDCl3, 400 MHz, δ ppm):
3.77(3H, s, O-CH3), 6.87(1H, d, J = 15.6 Hz, -CO-CH=), 7.09–
7.48(7H, m, J = 6.6–8.8 Hz, Ar-H& Th-H), 7.60(1H, d, J = 16 Hz, =CH-
Ar). MS: m/z (M+1) +244. Anal. calcd. for C14H12O2S: C, 68.83; H,
4.95; S, 13.12. Found: C, 68.73; H, 4.89; S, 13.71.
2.3.4. 3-[4-(dimethyl amino) phenyl]-1-(thiophen-2-yl)
prop-2-en-1-one (Td)
Orange, yield 81%, m.p.94 °C. FT-IR (KBr) vmax/cm−1: 1631(C = O),
1517(CH = CH), 735(C-S-C). 1H NMR (CDCl3, 400 MHz, δ ppm):
3.17(6H, s, N-(CH3)2), 6.80(1H, d, J = 15.2 Hz, -CO-CH=), 7.09–
7.76(7H, m, J = 6.6–8.8 Hz, Ar-H& Th-H), 7.83(1H, d, J = 15.6 Hz,
=CH-Ar). MS: m/z (M+1) 257. Anal. calcd. for C15H15NOS: C, 70.01;
H, 5.87; S, 12.46. Found: C, 70.13; H, 5.83; S, 12.31.
Fig. 1 – Design of thiophene based chalcone for the
recognition of MOA isoforms.
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2.3.5. 3-(3-nitrophenyl)-1-(thiophen-2-yl)
prop-2-en-1-one (Te)
Brown, yield 96%, m.p.102 °C. FT-IR (KBr) vmax/cm−1: 1651(C = O),
1527(CH = CH), 1350(N-O) 734(C-S-C). 1H NMR (CDCl3, 400 MHz,
δ ppm): 6.45(1H, d, J = 16 Hz, -CO-CH=), 7.43–7.82(7H, m, J = 6.6–
8.8 Hz, Ar-H& Th-H), 7.91(1H, d, J = 16 Hz, =CH-Ar). MS: m/z (M+1)
259. Anal. calcd. for C13H9NO3S: C, 60.22; H, 3.50; S, 12.37. Found:
C, 60.18; H, 3.43; S, 12.34.
2.3.6. 3-(2-hydroxyphenyl)-1-(thiophen-2-yl)
prop-2-en-1-one (Tf)
Light brown, yield 58%, m.p.150 °C. FT-IR (KBr) vmax/cm−1:
1651(C = O), 3246(Ar-OH), 1643(C = O), 1512(CH = CH), 715(C-S-
C). 1H NMR (CDCl3, 400 MHz, δ ppm): 5.23(1H, s, Ar-OH), 6.43(1H,
d, J = 15.2 Hz, -CO-CH=), 7.41–7.77(7H, m, J = 6.6–8.8 Hz, Ar-H&
Th-H), 7.86(1H, d, J = 15.6 Hz, =CH-Ar). MS: m/z (M+1) +230. Anal.
calcd. for C13H10O2S: C, 67.80; H, 4.38; S, 13.92. Found: C, 67.82;
H, 4.31; S, 12.94.
2.3.7. 3-(4-hydroxyphenyl)-1-(thiophen-2-yl)
prop-2-en-1-one (Tg)
Light brown, yield 52%, m.p.154 °C. FT-IR (KBr) vmax/cm−1:
1651(C = O), 3254(Ar-OH), 1645(C = O), 1510(CH = CH), 718(C-S-
C). 1H NMR (CDCl3, 400 MHz, δ ppm): 5.31(1H, s, Ar-OH), 6.33(1H,
d, J = 15.2 Hz, -CO-CH=), 7.44–7.81(7H, m, J = 6.6–8.8 Hz, Ar-H&
Th-H), 7.92(1H, d, J = 15.6 Hz, =CH-Ar). MS: m/z (M+1) +230. Anal.
calcd. for C13H10O2S: C, 67.80; H, 4.38; S, 13.92. Found: C, 67.84;
H, 4.36; S, 12.92.
2.4. ADME studies
An in silico study of the synthesized compounds was per-
formed for the prediction of ADME properties.Total polar surface
area (TPSA), miLog P, number of rotatable bonds, number of
hydrogen donor and acceptor atoms were calculated on the
basis of Lipinski’s rule of five (Lipinski et al., 2001). Blood brain
barrier prediction was done by utilizing a web based program
(www.cbligand.org/BBB/). The compounds with positive values
can cross readily in the BBB, while compounds with negative
values are poorly distributed to the brain.
2.5. Toxicity estimation
It was noticed that too many compounds were terminated in
clinical development because of unsatisfactory pharmacoki-
netics or in silico ADME studies. It is now possible to predict
activity and toxicity risks of compounds through reliable bio-
informatics tools, e.g., Osiris calculator (Sander et al., 2009). In
the present study, we calculated toxicity risks parameters such
as mutagenicity, tumorigenicity, irritation and reproductive tox-
icity issues of thiophene based chalcones.
2.6. Molecular docking studies
Crystallographic structures 2BXR (hMAO-A) and 2BYB (hMAO-
B) were retrieved from www.rcsb.org (Binda et al, 2007; De
Colibus et al, 2005; Edmondson et al, 2007). The protein prepa-
ration used in the current study was carried out Protein
Preparation Wizard of Maestro −8.4 (Schrodinger LLC). Initially,
water and covalently linked ligands were deleted, and bond
order was corrected for flavin adenine dinucleotide (FAD). After
assigning charge and protonation state, finally, energy mini-
mization was done using OPLS2005 force field. All the ligands
were energetically minimized by Molecular Orbital Package
(MOPAC) method until the RMS gradient attained a value smaller
than 0.0001 kcal/mol Å. AutoDock tool automatically com-
putes Gasteiger charges and determines rotatable bonds of the
ligand to be able to generate different conformers for the
docking (Morris et al., 2009). Receptor grids were generated using
60 × 60 × 60 grid points in xyz with grid spacing of 0.375 Å. Grid
box was centred on N5 atom of FAD. Map types were gener-
ated using autogrid4. The Lamarckian genetic algorithm was
used for all molecular docking simulations. Docking was carried
out with following parameters with number of runs: 50, popu-
lation size: 150, number of evaluations: 2,500,000 and number
of generations: 27,000 numbers of generations (Mathew et al.,
2014c; Nayak et al., 2013).
3. Results and discussion
3.1. Chemistry
The synthetic strategy involves in the formation titled deriva-
tives was shown in Fig. 2. The IR spectra of C = O group in the
thiophene based chalcone showed at a peak 1681–1631 cm−1.
The carbonyl frequency of the chalcone is reduced by the par-
ticipation of conjugated system connected with a phenyl ring.
The presence of electron donating group in the phenyl system
participate more conjugation towards the carbonyl system and
reduce the C = O frequency. The 1H nuclear magnetic reso-
nance (NMR) spectra showed unsaturated and aromatic protons
at δ 6.68–7.56. It has been noted that the up-field proton of α
carbon and down-field proton of β carbon coupled with methine
proton with coupling constants (15.2–16.0 Hz). In MS spectra,
the fragment peaks which correspond to loss of –SH, C6H5 from
the molecular ion are consistent with the postulated structure.
3.2. ADMETox prediction
The zero violation of rule five indicated the probability of syn-
thesized molecules for its oral bioavailability and can be
achieved with an appropriate balance between solubility and
partitioning properties. Topological polar surface area (TPSA)
allows prediction of transport properties of drug candidates
in the intestines and blood–brain barrier crossing (Wang et al.,
Fig. 2 – ADME-Tox prediction.
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1997). In this series, Tb gave a BBB score of 0.119 and a low
TPSA of 17.07. The low score of TPSA suggested that this mol-
ecule preferentially act as hydrophobic in nature and can easily
transport through the blood brain barrier. The ADME profile of
the titled derivatives was shown in Table 1. In the toxicologi-
cal profile of the compounds, Tb, Te and Tg may exhibit
medium mutagenic property, but in case of Tg, high risk in the
reproductive system is predicted. Remaining all the thienyl
chalcones under the present study were free from toxicity issues
predicted by the software (Table 2).
3.3. Molecular docking studies
In the current molecular modelling study, AutoDock 4.2.1 was
employed to perform automated molecular docking for the in-
hibitors of MAO isoforms (Rizvi et al., 2013). Binding energy and
calculated inhibition constant of thiophene based chalcones
towards MAO and B were shown in Table 3. Docking studies
suggested that thiophene based chalcones have compara-
tively more recognition capacity towards MAO-B than MAO-A.
In this series, 3-[4-(dimethyl amino) phenyl]-1-(thiophen-2-yl)
prop-2-en-1-one (Td) showed a docking score of −8.46 kcal/mol
and calculated inhibition constant of about 0.64 μM towards
the active site of MAO-B.
Visual inspection of the pose of Td into the MAO-B active
binding site revealed that the compound Td is efficiently in-
serted into the aromatic cage framed by Tyr 188, Tyr 326 Tyr398,
Tyr435 and the FAD aromatic ring. The binding is further sta-
bilized by the π-π stacking interaction between dimethyl amino
substituted phenyl unit of thiophene chalcone and Tyr 188
(Fig. 3). When compared to the MAO-A binding mode of all syn-
thesized chalcones, the thiophene core of the scaffold is close
proximity towards the FAD of MAO-B. The thiophene nucleus
fairly sandwiched between the aromatic cage of Tyr 398 and
Tyr 435. So such interaction, in fact, was expected to strengthen
the charger-transfer bonding interaction between the non-
bonding electrons of sulphur atom with isoalloxazine unit of
FAD, which was recognized as one of the major interaction of
MAOIs (Manna et al., 2002).
In order to establish a detailed binding analysis of heteroaryl
chalcone, the scaffold can be split into three fragments namely,
thiophene ring, three carbon α, β-unsaturated carbonyl spacer
Table 1 – ADME profile of the titled derivatives (Ta-Tg).
Compound
code
TPSA miLogP nRtb nON nOHNH Rule of
violation
BBB
prediction
Ta 17.07 3.71 3 1 0 0 0.107
Tb 17.07 4.39 3 1 0 0 0.119
Tc 26.31 3.77 4 2 0 0 0.031
Td 20.31 3.81 4 2 0 0 0.057
Te 62.90 3.65 4 4 0 0 0.023
Tf 37.30 3.471 3 2 1 0 0.055
Tg 37.30 3.23 3 2 1 0 0.039
Table 2 – Toxicity prediction of titled derivatives (Ta-Tg).
Compound
code
Mutagenic Tumorigenic Irritant Reproductive
effect
Ta No No No No
Tb Medium No No No
Tc No No No No
Td Yes Yes No No
Te Medium No No No
Tf No No No No
Tg Medium No No Yes
Table 3 – Molecular docking studies of (Ta-Tg) towards MAO-A and B.
Compound
code
Binding energy for
MAO-A (Kcal/mol)
Binding energy for
MAO-B (Kcal/mol)
Calculated Ki
MAO-A (μM)
Calculated Ki
MAO-B (μM)
Ta −7.28 −7.77 4.62 2.01
Tb −7.77 −8.29 2.0 0.83
Tc −7.95 −8.14 1.49 1.08
Td −8.00 −8.43 1.36 0.64
Te −8.24 −8.10 0.91 1.15
Tf −7.64 −8.02 2.51 1.33
Tg 7.46 8.00 3.40 1.38
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unit, and phenyl system. The substitution pattern of thio-
phene based chalcones was carefully selected to confer the
effect of substituent in the phenyl system. Thus, electron do-
nating groups to phenyl system such as methoxy, dimethyl
amino, hydroxyl and electron withdrawing group such as chloro
and nitro were chosen as substituents on the chemical struc-
ture of the target compounds. In this design, the para-
substitution of phenyl system with electron donating groups
such as dimethyl amino, methoxyl and lipophilic halogen also
can contribute good binding interaction towards MAO-B.
4. Conclusion
In conclusion, we have shown the detailed binding analysis
of thiophene based chalcones with the inhibitor binding cavity
of MAO isoforms. The molecular docking study gave a new
insight of thiophene based chalcones in recognition pattern
of both MAO-A and B.To the best of our knowledge, we are first
to report the molecular recognition of monoamine oxidase ca-
pacity of thiophene based chalcones. This could provide the
development of some effective scaffold against the disease pre-
cipitated by increased metabolism of biogenic amines in the
central nervous system.
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